In contrast, IL-33 did not exert any direct action on melanoma cells and its combination with DAC did not further decrease tumor growth in either 2D or 3D settings, corroborating that the antitumor functions of this cytokine are attributable to the stimulation of immune response [2]. This evidence concerns the gene IL33 and neoplasm.